Pharma Co. Investors Can Serve China Execs Via US Counsel

Law360, Los Angeles (December 11, 2013, 7:46 PM EST) -- A New Jersey federal judge on Wednesday said that shareholders bringing a derivative action against the leadership of American Oriental Bioengineering Inc. can serve the company’s China-based officers and directors through their U.S.-based counsel.

U.S. Magistrate Judge Tonianne J. Bongiovanni matched an earlier California court’s decision in a parallel suit, saying the plaintiffs could still reasonably reach the company’s foreign directors through the company’s U.S. attorneys.

Judge Bongiovanni was unpersuaded by the executives’ argument that the shareholders should have first exhausted their options for service under...
To view the full article, register now.